Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Precigen
PGEN
$2.59B
| $1.63M | ﹤0.01% |
284,587
-48,446
| -15% | -$329K |
|
3077
PUT
Goodyear
GT
$1.85B
| $1.62M | ﹤0.01% |
112,600
+9,200
| +9% | +$123K |
|
|
GBT
3078
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.62M | ﹤0.01% |
33,420
-22,258
| -40% | -$1.16M |
|
3079
First Merchants
FRME
$2.67B
| $1.62M | ﹤0.01% |
43,041
+6,317
| +17% | +$236K |
|
|
XENT
3080
CALL
DELISTED
Intersect ENT, Inc
XENT
| $1.62M | ﹤0.01% |
+95,000
| New | +$1.73M |
|
3081
Extreme Networks
EXTR
$3.15B
| $1.61M | ﹤0.01% |
221,946
-2,356
| -1% | -$17K |
|
3082
Worthington Enterprises
WOR
$2.86B
| $1.61M | ﹤0.01% |
72,617
-45,135
| -38% | -$1.05M |
|
3083
Red Rock Resorts
RRR
$3.62B
| $1.61M | ﹤0.01% |
79,416
+32,889
| +71% | +$686K |
|
3084
Vishay Intertechnology
VSH
$5.43B
| $1.61M | ﹤0.01% |
95,233
-40,325
| -30% | -$662K |
|
|
SOHU
3085
Sohu.com
SOHU
$357M
| $1.61M | ﹤0.01% |
158,409
+143,936
| +995% | +$1.69M |
|
|
ATNX
3086
DELISTED
Athenex, Inc. Common Stock
ATNX
| $1.61M | ﹤0.01% |
6,619
+3,195
| +93% | +$1.04M |
|
3087
NBT Bancorp
NBTB
$2.74B
| $1.61M | ﹤0.01% |
43,966
-8,446
| -16% | -$309K |
|
|
NVO
3088
Novo Nordisk
NVO
$209B
| $1.61M | ﹤0.01% |
62,150
+61,148
| +6,103% | +$1.55M |
|
3089
Canadian Solar
CSIQ
$1.08B
| $1.61M | ﹤0.01% |
85,130
+46,687
| +121% | +$1.02M |
|
3090
WSFS Financial
WSFS
$4.15B
| $1.61M | ﹤0.01% |
36,411
+1,431
| +4% | +$60.2K |
|
|
RETA
3091
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.61M | ﹤0.01% |
20,000
| – | – |
|
|
PTR
3092
CALL
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.61M | ﹤0.01% |
31,600
+28,600
| +953% | +$1.48M |
|
3093
CALL
DaVita
DVA
$11.7B
| $1.6M | ﹤0.01% |
28,100
-7,300
| -21% | -$424K |
|
3094
PUT
ProShares UltraShort Bloomberg Crude Oil
SCO
$728M
| $1.6M | ﹤0.01% |
1,234
+39
| +3% | +$52.8K |
|
3095
Ormat Technologies
ORA
$6.64B
| $1.6M | ﹤0.01% |
21,563
-6,438
| -23% | -$444K |
|
3096
CNO Financial Group
CNO
$5.11B
| $1.6M | ﹤0.01% |
101,037
-36,236
| -26% | -$573K |
|
3097
CALL
Southern Copper
SCCO
$166B
| $1.6M | ﹤0.01% |
50,484
+32,685
| +184% | +$1.04M |
|
|
MGLN
3098
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.6M | ﹤0.01% |
25,717
-8,853
| -26% | -$590K |
|
|
SYKE
3099
DELISTED
SYKES Enterprises Inc
SYKE
| $1.6M | ﹤0.01% |
52,079
+1,202
| +2% | +$34.7K |
|
3100
PUT
Ball Corp
BALL
$16.8B
| $1.59M | ﹤0.01% |
21,900
+17,100
| +356% | +$1.27M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.